These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18057060)

  • 1. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.
    Suntharalingam J; Goldsmith K; van Marion V; Long L; Treacy CM; Dudbridge F; Toshner MR; Pepke-Zaba J; Eikenboom JC; Morrell NW
    Eur Respir J; 2008 Apr; 31(4):736-41. PubMed ID: 18057060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance.
    Li JF; Lin Y; Yang YH; Gan HL; Liang Y; Liu J; Yang SQ; Zhang WJ; Cui N; Zhao L; Zhai ZG; Wang J; Wang C
    PLoS One; 2013; 8(7):e69635. PubMed ID: 23894515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
    Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
    Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen-Aα THR312ALA Polymorphism is Associated to Chronic Thromboembolic Pulmonary Hypertension in Turkey.
    Çörtük M; Yıldızeli B; Kurar E; Kayış SA; Tanrıverdi E; Çetinkaya E
    Anatol J Cardiol; 2023 Mar; 27(3):153-159. PubMed ID: 36856592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.
    Morris TA; Marsh JJ; Chiles PG; Magaña MM; Liang NC; Soler X; Desantis DJ; Ngo D; Woods VL
    Blood; 2009 Aug; 114(9):1929-36. PubMed ID: 19420351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension.
    Jan K; Pavel J; Renata C; Daniela D; Petra B; Martin Š; Zuzana Z; Tomáš K
    Clin Appl Thromb Hemost; 2024; 30():10760296241271369. PubMed ID: 39150410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
    Hoppe B; Tolou F; Dörner T; Kiesewetter H; Salama A
    Thromb Haemost; 2006 Oct; 96(4):465-70. PubMed ID: 17003923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
    Wong CL; Szydlo R; Gibbs S; Laffan M
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):201-6. PubMed ID: 20182352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
    Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Research in Chronic Thromboembolic Pulmonary Hypertension.
    Opitz I; Kirschner MB
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.
    Carter AM; Catto AJ; Kohler HP; Ariëns RA; Stickland MH; Grant PJ
    Blood; 2000 Aug; 96(3):1177-9. PubMed ID: 10910940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion.
    Satra M; Samara M; Wozniak G; Tzavara C; Kontos A; Valotassiou V; Vamvakopoulos NK; Tsougos I; Aleporou-Marinou V; Patrinos GP; Kollia P; Georgoulias P
    Pharmacogenomics; 2011 Feb; 12(2):195-203. PubMed ID: 21332313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis.
    Kominami S; Tanabe N; Ota M; Naruse TK; Katsuyama Y; Nakanishi N; Tomoike H; Sakuma M; Shirato K; Takahashi M; Shibata H; Yasunami M; Chen Z; Kasahara Y; Tatsumi K; Kuriyama T; Kimura A
    J Hum Genet; 2009 Feb; 54(2):108-14. PubMed ID: 19165231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No increased prevalence of the factor V Leiden mutation in chronic major vessel thromboembolic pulmonary hypertension (CTEPH).
    Lang IM; Klepetko W; Pabinger I
    Thromb Haemost; 1996 Sep; 76(3):476-7. PubMed ID: 8883290
    [No Abstract]   [Full Text] [Related]  

  • 16. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
    Gohil R; Peck G; Sharma P
    Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors in chronic thromboembolic pulmonary hypertension].
    Jiménez D; Gaudó J; Sueiro A
    Arch Bronconeumol; 2009 Jun; 45 Suppl 6():11-4. PubMed ID: 20542195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.
    Carter AM; Catto AJ; Grant PJ
    Circulation; 1999 May; 99(18):2423-6. PubMed ID: 10318664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications.
    Camilleri RS; Peebles D; Portmann C; Everington T; Cohen H
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):139-47. PubMed ID: 15091001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension.
    Jastrzebska M; Goracy I; Naruszewicz M
    Thromb Res; 2003 Jun; 110(5-6):339-44. PubMed ID: 14592559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.